2-(3-cyclopentyl-1-propyn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

1-(3-fluoro-4-morpholin-4-ylphenyl)ethanone, 97.0%, 100mg

4,4,5,5-Tetramethyl-2-(3-methylbut-2-en-1-yl)-1,3,2-dioxaborolane, 95.0%, 1g

2-((2,4-Dimethylphenyl)thio)aniline, 97%, 1g

2-AMINO-4-METHOXY-5-(3-MORPHOLINOPROPOXY)BENZAMIDE, 95%, 5mg

2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 98%, 1g

Seringue microlitre GASTIGHT® série 1000, 10,0 ml, 1010 TLL, 1 pièce

(3,3-difluoropiperidin-4-yl)methanol hydrochloride, 95.0%, 500mg

3-Oxo-4-aza-5alpha-androst-1-ene-17beta-carboxylic Acid>98.0%(HPLC)(T)5g

Balance semi-micro et analytique série ALJ Version standard, non certifiée, 0,0001 g, 310 g, ALJ310-4A (W)

4-Chloropyridazin-3-ol, 95.0%, 25g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(o-tolyl)propanoic acid, 97%, 1g

6-Fluoro-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid, 97%, 250mg